A192621
A192621 性质
沸点 | 738.3±60.0 °C(Predicted) |
---|---|
密度 | 1.233±0.06 g/cm3(Predicted) |
储存条件 | -20°C |
形态 | 粉末 |
酸度系数(pKa) | 3.52±0.60(Predicted) |
颜色 | 白色至米色 |
A192621 用途与合成方法
ET B 4.5 nM (IC 50 ) |
ET B 8.8 nM (Ki) |
ET A 4280 nM (IC 50 ) |
ET A 5600 nM (Ki) |
A-192621 (1-100 μM; 48 hours; PASMCs) treatment markedly reduces the cell viability of PASMCs in a dose-dependent manner.
A-192621 (1-100 μM; 48 hours; PASMCs) treatment significantly increases the caspase-3/7 activity and cleaved caspase-3 expression in PASMCs. A-192621 induces apoptosis in a dose-dependent manner and increases the cells' susceptibility to apoptosis by Doxorubicin treatment.
Cell Viability Assay
Cell Line: | Pulmonary arterial smooth muscle cells (PASMCs) with Doxorubicin |
Concentration: | 1 μM, 10 μM, 50 μM, 100 μM |
Incubation Time: | 72 hours |
Result: | The viability of PASMCs was significantly decreased in a dose-dependent manner. |
Western Blot Analysis
Cell Line: | Pulmonary arterial smooth muscle cells (PASMCs) with Doxorubicin |
Concentration: | 1 μM, 10 μM, 100 μM |
Incubation Time: | 72 hours |
Result: | The caspase-3/7 activity in PASMCs was significantly increased in a dose-dependent manner. |
A-192621 (30-100 mg/kg; oral administration; daily; for 3 days; male Sprague-Dawley rats) treatment inhibits both dilatory and pressor responses induced by S6c mediated by ET B with an ED 50 value of 30 mg/kg, and failed to inhibit the ET-1-induced pressor response mediated by ET A . A-192621 alone causes elevation of arterial blood pressure and an elevation in the plasma ET-1 level in the conscious normotensive rat.
Animal Model: | Male Sprague-Dawley rats (250-350 g) |
Dosage: | 30 mg/kg 100 mg/kg |
Administration: | Oral administration; daily; for 3 days |
Result: | Inhibited both dilatory and pressor responses induced by S6c mediated by ET B with an ED 50 value of 30 mg/kg. |
A192621 价格(试剂级)
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024-01-25 | HY-120295 | A192621 | 195529-54-5 | 5mg | 2900 |
2024-01-25 | HY-120295 | 10 mM * 1 mLin DMSO | 3564 |